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Abstract
Acute chorioamnionitis of infectious origin and chronic chorioamnionitis of immunologic origin
are two major placental lesions of spontaneous preterm birth with elevated amniotic fluid
interleukin-6 and CXCL10 concentrations, respectively. The changes in the amniotic fluid
proteome associated with intra-amniotic infection and acute chorioamnionitis are well-defined, yet
alterations unique to chronic chorioamnionitis remain to be elucidated. This study was conducted
to determine those amniotic fluid proteins changing specifically in the presence of chronic
chorioamnionitis. Amniotic fluid obtained from acute chorioamnionitis, chronic chorioamnionitis,
and gestational age-matched controls were analyzed by 2-dimensional difference in gel
electrophoresis and MALDI-TOF analyses. The type of histologic inflammation was used to
define each condition in preterm labor cases (n=125) and term not in labor cases (n=22); and the
amniotic fluid concentrations of interleukin-6, CXCL8, CXCL10, and prostaglandin F2α were also
measured by specific immunoassays. Among preterm labor cases, thirty-one differentially
expressed proteins were identified in chronic chorioamnionitis cases, as compared to both acute
chorioamnionitis and control cases. Importantly, glycodelin-A, which maintains maternal
tolerance against an allogeneic fetus, was decreased in chronic chorioamnionitis, while
haptoglobin was increased. We report the amniotic fluid proteome of chronic chorioamnionitis for
the first time, and the findings herein strongly suggest that there is a pathophysiological
association between the changes of immunomodulatory proteins in the amniotic fluid and chronic
chorioamnionitis, a histologic manifestation of maternal anti-fetal allograft rejection.
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Introduction
Human parturition involves the activation of pro-inflammatory cascades in gestational
tissues, such as the chorioamniotic membranes, in cases of spontaneous labor at term and
preterm birth due to intra-amniotic infection. Not surprisingly, in both conditions there is an
increased expression of prostaglandin-endoperoxide synthase 2 (PTGS2) in the
chorioamniotic membranes [1–3], and the amniotic fluid prostaglandin concentrations are
increased [4–7]. Acute chorioamnionitis following microbial invasion of the amniotic cavity
(MIAC) is a major pathological lesion found in spontaneous preterm births (preterm labor
and preterm prelabor rupture of membranes) [8–10]. However, our recent analysis
demonstrated that chronic chorioamnionitis is more common in spontaneous preterm birth
cases, found in 34% of preterm labor with intact membranes cases and 39% of preterm
prelabor rupture of membranes cases. This lesion was also observed in 23% of term
preeclampsia and 16% of preterm preeclampsia cases suggesting its link with the
immunopathology of preeclampsia and indicated preterm birth as well [11,12].
Chronic chorioamnionitis, defined as the amniotropic infiltration of maternal T cells, is
considered a histologic manifestation of maternal anti-fetal allograft rejection and graft-
versus-host disease in the placenta [11,13,14]. Therefore, a major proportion of preterm
births seems to be due to either intra-amniotic infection or allograft rejection. While
amniotic fluid interleukin-6 (IL-6) is a sensitive marker of intra-amniotic infection and acute
chorioamnionitis [15–17], chronic chorioamnionitis is associated with elevated intra-
amniotic T cell chemokine CXC-motif ligand-10 (CXCL10) concentration and increased
CXCL9, CXCL10, and CXCL11 mRNA expressions in the chorioamniotic membranes [11].
Intra-amniotic infection- and acute chorioamnionitis-associated changes in the amniotic
fluid proteome have been elegantly addressed in previous studies [18–20], yet those
associated with chronic chorioamnionitis remain to be elucidated. The assessment of
changes in the amniotic fluid proteome could unveil key alterations in the intra-amniotic
environment leading to the development of chronic chorioamnionitis and preterm birth. This
study was conducted to determine specific changes in the abundance of amniotic fluid
proteins in the presence of chronic chorioamnionitis.
Materials and methods
Patient materials
This cross-sectional study included 125 women with a singleton pregnancy who presented
with preterm labor with intact membranes and 22 women with normal pregnancy at term not
in labor. The study was approved by the Institutional Review Boards of participating
institutions, and all participants provided written informed consent for the collection of
biological materials and clinical data. Amniotic fluid samples were obtained by
transabdominal amniocentesis performed to assess the microbial status of the amniotic
cavity or fetal lung maturity. Histologic diagnosis of placental lesions was done by
examination of hematoxylin and eosin stained sections of the chorioamniotic membranes
(n=1), placental disc (n=2), and umbilical cord (n=1) in each case. The diagnosis of acute
chorioamnionitis was made based on the criteria previously described [21]. The diagnosis of
chronic chorioamnionitis was made when lymphocytic infiltration into the chorionic
trophoblast layer or chorioamniotic connective tissue was observed. The extent of chronic
chorioamnionitis was graded 1 when there were more than two foci or patchy inflammation,
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and 2 when diffuse inflammation was present. The stage of inflammation was scored as 1 if
amniotropic lymphocytic infiltration was limited to the chorionic trophoblast layer, and 2 if
lymphocytic infiltration extended into the chorioamniotic connective tissue [11].
Enzyme-linked immunosorbent assay (ELISA)
The amniotic fluid concentrations of IL-6 (R&D Systems, Minneapolis, MN, USA), CXCL8
(R&D Systems), CXCL10 (R&D Systems), PGF2α (Assay Designs, Inc., Ann Arbor, MI,
USA), and glycodelin-A (DRG Diagnostics, Marburg, Germany) were measured by specific
immunoassays according to the manufacturers’ instructions.
2-Dimensional Difference in Gel Electrophoresis (2D-DIGE)
Three gestational age-matched amniotic fluid samples of each histologic group [no
inflammation-control (gestational age: 24.9, 27.4, 33.4 weeks), acute chorioamnionitis
(gestational age: 25.3, 27.4, 33.4 weeks), chronic chorioamnionitis (gestational age: 25.1,
28.9, 33.9 weeks)] were selected. These three samples were then pooled to represent each
group. Methanol was added to the pooled amniotic fluid samples (volume ratio 9:1), and the
precipitated proteins were resolubilized in lysis buffer [30 mM Tris-HCl (pH 8.8), 7 M urea,
2 M thiourea, 4% CHAPS]. Thirty μg of proteins from each pooled sample were labeled
with Cy2, Cy3, and Cy5, respectively. The labeling reaction was stopped by adding 1.0 ul of
10 mM Lysine to each sample, and incubating in the dark on ice for an additional 15 min.
The labeled samples were then mixed with 2X sample buffer [8 M urea, 4% CHAPS, 20 mg/
ml dithiothreitol (DTT), 2% pharmalytes] and 100 μl destreak rehydration buffer (7 M urea,
2 M thiourea, 4% CHAPS, 20 mg/ml DTT, 1% pharmalytes) to make a total volume of 250
μl. The samples were mixed, spun, and then loaded into a strip holder. After isoelectric
focusing (pH 3–10), IPG strips were incubated in equilibration buffer-1 (50 mM Tris-HCl,
pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 10 mg/ml DTT) for 15 min with gentle shaking,
and then rinsed in equilibration buffer-2 [50 mM Tris-HCl (pH 8.8), 6 M urea, 30%
glycerol, 2% SDS, 45 mg/ml DTT] for 10 min with gentle shaking. Following
electrophoresis in a 12% SDS-polyacrylamide gel at 15°C, the gel was scanned using
Typhoon TRIO (Amersham BioSciences, Piscataway, NJ, USA). Scanned images were then
analyzed by Image Quant software version 6.0 (Amersham BioSciences), followed by
differential in-gel analysis using DeCyder software version 6.5 (GE Healthcare, Piscataway,
NJ, USA), to obtain the fold-changes in protein expression.
Mass Spectrometry
The spots of interest were picked up by Ettan Spot Picker (Amersham BioSciences) and
digested in-gel with modified porcine trypsin protease (Trypsin Gold; Promega, Madison,
WI, USA). The digested tryptic peptides were desalted by Zip-tip C18 (Millipore, Billerica,
MA, USA). Peptides were eluted from the Zip-tip with 0.5 μl of matrix solution (5 mg/ml of
α-cyano-4-hydroxycinnamic acid in 50% acetonitrile, 0.1% trifluoroacetic acid, 25 mM
ammonium bicarbonate) and spotted on the MALDI plate (model ABI 01-192-6-AB).
MALDI-TOF and TOF/TOF mass spectrometry were performed on an ABI 4700 mass
spectrometer (Applied Biosystems, Framingham, MA, USA). MALDI-TOF mass spectra
were acquired in reflectron-positive ion mode, averaging 4000 laser shots per spectrum.
TOF/TOF mass spectrometry fragmentation spectra were acquired for each sample,
averaging 4000 laser shots per fragmentation spectrum on each of the 10 most abundant ions
present in each sample. Both the resulting peptide mass and the associated fragmentation
spectra were submitted to a GPS Explorer workstation equipped with a MASCOT search
engine (Matrix Science Ltd., London, United Kingdom) to search the redundant database of
the National Center for Biotechnology Information (NCBInr). Searches were performed
without constraining protein molecular weight or isoelectric point, with variable
carbamidomethylation of cysteine and oxidation of methionine residues, and with one
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missed cleavage also allowed in the search parameters. Candidates with either a protein
score of C.I.% or Ion C.I.% greater than 95 were considered significant.
Immunoblotting
Immunoblotting for haptoglobin was done using 3.5 μl of amniotic fluid. Electrophoresis
was done under reducing conditions in 12% SDS-PAGE, and proteins were electro-blotted
onto polyvinylidene difluoride membranes. The membranes were incubated with mouse
monoclonal anti-haptoglobin-beta antibody (Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA), and then with HRP-conjugated anti-mouse IgG. Chemiluminescence was
detected using a ChemiGlow West kit (Alpha Innotech Corporation, San Leandro, CA,
USA). β-haptoglobin density was analyzed by FluorChem™ SP densitometry using
AlphaEase®FC Software (Version 4.1.0; Alpha Innotech Corporation).
Immunohistochemistry
Formalin-fixed, paraffin-embedded 5-μm-thick tissue sections of the chorioamniotic
membranes obtained from preterm labor cases without inflammation (n=5), with acute
chorioamnionitis (n=5), and chronic chorioamnionitis (n=5) were used for immunostaining
using a Ventana Discovery automatic staining system (Ventana Medical Systems, Tucson,
AZ, USA). Immunostaining was performed using a mouse monoclonal anti-CD8 antibody
(1:100 diluted, Dako, Carpinteria, CA, USA), a rabbit monoclonal anti-pregnancy-
associated endometrial alpha-2 globulin (PAEP, glycodelin-A) antibody (1:100 diluted, Life
Span Biosciences, Inc., Seattle, WA, USA), and a mouse monoclonal anti-haptoglobin beta
antibody (1:100 diluted, Santa Cruz Biotechnology Inc.). Chromogen reaction was done
using the DiscoveryR DAB Map Kit (Ventana Medical Systems).
Statistical analysis
Normality of the data distribution was tested using the Kolmogorov-Smirnov test.
Comparisons among the study groups were performed by the unpaired t-test and post hoc
analysis or Kruskall-Wallis test and Mann-Whitney U-test for continuous variables, as well
as by the χ2-test and Fisher’s exact test for categorical variables as appropriate. Spearman
rank correlation was used to examine the relationship of PGF2α concentration with IL-6 and
with CXCL10 concentrations in amniotic fluid and between glycodelin-A concentration and
gestational age. A p value of < 0.05 was considered significant.
Results
Amniotic fluid IL-6, CXCL8, CXCL10, and PGF2α
The demographics and clinical characteristics of the study population are shown in Table 1,
and histological and immunohistochemical features of each group are shown in Figures 1A–
1F. Amniotic fluid cultures for aerobes, anaerobes and Mycoplasmas were available in all
preterm labor cases. Among 71 cases without inflammation (control), one case had a
positive culture. Amniotic fluid cultures were positive in four of the 14 cases of acute
chorioamnionitis (28.6%). Cultures were negative in all chronic chorioamnionitis cases
(n=40). To further characterize acute chorioamnionitis and chronic chorioamnionitis cases,
amniotic fluid IL-6, CXCL8, CXCL10, and PGF2α concentrations were measured by
immunoassay.
The median IL-6 concentration was higher in acute chorioamnionitis cases (median: 7.2 ng/
ml, range: 0.4–388.9 ng/ml) than in chronic chorioamnionitis cases (median 0.6 ng/ml, range
0.1–15.2 ng/ml; p=0.002) or in control cases (median: 0.6 ng/ml, range: 0.0–14.8 ng/ml;
p=0.001) (Figure 2A). Among acute chorioamnionitis cases, IL-6 concentration was
significantly higher in those with positive amniotic fluid culture compared to those with
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negative culture (median 217.3, range 18.5–388.9 ng/ml vs. median 1.0, range 0.4–241.1 ng/
ml; p=0.014). Using a concentration cut-off of 12.4 ng/ml identified with a receiver-
operating characteristic (ROC) curve (area under the curve (AUC): 0.979; 95% CI: 0.931–
1.027; p<0.001), IL-6 had sensitivity, specificity, positive predictive value, and negative
predictive value of 100%, 87.5%, 66.7% and 100%, respectively, for acute chorioamnionitis
in patients who delivered within seven days of amniocentesis.
The median concentration of CXCL8 was significantly higher in acute chorioamnionitis
cases (median 3.4 ng/ml, range: 0.1–467.0 ng/ml) than in chronic chorioamnionitis cases
(median 0.5 ng/ml, range: 0.1–15.7 ng/ml; p=0.048) or in control cases (median 0.4 ng/ml,
range: 0.1–14.8 ng/ml; p=0.019) (Figure 2B).
The median amniotic fluid CXCL10 concentration was higher in chronic chorioamnionitis
cases (median: 2.7 ng/ml, range: 0.0–20.8 ng/ml) than in the acute chorioamnionitis cases
(median: 1.1 ng/ml, range: 0.4–4.5 ng/ml; p=0.02) and the control cases (median: 1.1 ng/ml,
range: 0.0–5.8 ng/ml; p<0.001) (Figure 2C). Using a concentration cut-off of 1.1 ng/ml
identified with a ROC curve (AUC: 0.769; 95% CI 0.643–0.895; p=0.001), CXCL10 had
sensitivity, specificity, positive predictive value, and negative predictive value of 85.7%,
61%, 52.9% and 89.3%, respectively, for chronic chorioamnionitis in patients delivering
within 28 days of amniocentesis.
Preterm labor due to intra-amniotic infection is characterized by increased prostaglandin
concentrations in the amniotic fluid [4–7,22]. To determine whether chronic
chorioamnionitis shows comparable changes in the amniotic fluid prostaglandins, PGF2α
was also measured. The median amniotic fluid concentration of PGF2α was significantly
higher in cases with acute chorioamnionitis (median: 101.2 ng/ml, range: 2.4–2216.4 ng/ml)
compared to both chronic chorioamnionitis cases (median: 40.2 ng/ml, range: 6.7–514.6 ng/
ml; p=0.02) and control cases (median: 36.1 ng/ml, range: 1.9–1565.8 ng/ml; p=0.01), while
no differences were observed between chronic chorioamnionitis and control cases (Figure
2D). Among acute chorioamnionitis cases, PGF2α concentration tended to be higher in cases
with positive culture (median 704.8, range 183.4–2216.4 pg/ml vs. median 54.7, range2.4–
939.9 pg/ml; p=0.05). Amniotic fluid PGF2α concentration showed a moderate correlation
with that of IL-6 (Spearman rho coefficient: 0.384, p<0.001) but not with CXCL10
(Spearman rho coefficient: 0.062, p=0.5).
The amniotic fluid concentrations of IL-6 (median 0.5 ng/ml, range 0.2–1.8 ng/ml; Figure
3A), and CXCL10 (median 0.8 ngml, range 0.1–6.0 ng/ml Figure 3C) of normal pregnant
women at term were not different from those of preterm labor cases without histologic
inflammation. However, CXCL8 concentration (median 1.0 ng/ml, range 0.3–.3.9 ng/ml;
Figure 3B) and PGF2α concentration (median 155.3 pg/ml, range 11.8–1338.5 pg/ml; Figure
3D) of term cases were significantly higher than that of preterm labor cases (p=0.003 and
p<0.001 respectively).
2D-DIGE of Amniotic Fluid
Figure 4A shows the 2-D electrophoresis gel with 71 spots showing differentially expressed
proteins amongst the three groups. Differentially expressed spots with more than 2-fold
changes in chronic chorioamnionitis compared to acute chorioamnionitis or control cases
were analyzed (Figure 4B). Table 2 provides the list of 31 differentially expressed proteins
identified from 41 spots in 2D-DIGE analysis of pooled amniotic fluid samples from the
three groups (control, acute chorioamnionitis, and chronic chorioamnionitis). Several acute
phase proteins such as α-1-antichymotrypsin, α-1-antitrypsin, and haptoglobin were
increased in chronic chorioamnionitis. Several plasma proteins were also differentially
represented in chronic chorioamnionitis: plasminogen and transferrin were increased, while
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ceruloplasmin was decreased. Orosomucoid 2 and insulin-like growth factor binding protein
1 precursor were decreased in chronic chorioamnionitis compared to the controls but did not
change in acute chorioamnionitis. Interestingly, glycodelin-A was 6.1-fold and 5.5-fold
reduced in chronic chorioamnionitis compared to acute chorioamnionitis and controls,
respectively.
To confirm the results of 2D-DIGE, amniotic fluid glycodelin-A concentration was
measured by immunoassay. When all results from the cases were analyzed, there was no
difference among the groups (p = 0.2). When examining cases ≤ 32 weeks of gestation (n =
68), however, based on the fact that amniotic fluid glycodelin-A concentration rapidly
decreases by the end of the second trimester [23], and that two out of three amniotic fluid
samples used for 2D-DIGE were obtained before 29 weeks of gestation, median amniotic
fluid glycodelin-A concentration was significantly lower in chronic chorioamnionitis cases
(median: 1639.9 ng/ml, range: 45.2–12718.0 ng/ml) compared to control cases (median:
3184.3 ng/ml, range: 28.3–97991.2 ng/ml; p < 0.05) (Figure 5A). Glycodelin-A
concentration in acute chorioamnionitis cases (median: 3166.8 ng/ml, range: 278.9–55608.1
ng/ml) also tended to be higher than that found in chronic chorioamnionitis cases (p =
0.091). Such differences were not present in samples collected after 32 weeks (p = 0.9). This
seems to be associated with a marked physiological decrease in amniotic fluid glycodelin-A
concentration. Indeed, there was a significant negative correlation between glycodelin-A
concentration and gestational age at amniocentesis (Spearman rho coefficient = −0.479; p <
0.001). Even when the controls were divided into high and low amniotic fluid glycodelin-A
using median concentration as the cut-off value, the gestational age of low glycodelin-A
cases (median: 30.4 weeks, range: 26.6 – 32.0 weeks) was significantly higher than that of
high glycodelin-A cases (median: 27.4 weeks, range: 22.7 – 31.7 weeks). However, there
was no difference in gestational age between control and chronic chorioamnionitis cases,
indicating that decreased amniotic fluid glycodelin-A concentration is a feature of chronic
chorioamnionitis.
The differences in the amniotic fluid concentration of haptoglobin observed by 2D-DIGE
were further assessed by immunoblotting in a subgroup of samples associated with isolated
acute chorioamnionitis (n = 11), chronic chorioamnionitis (n = 16), and control cases (n =
16). Densitometric analysis of the immunoblotting results was performed. The abundance of
the β-subunit of haptoglobin in the amniotic fluid of cases collected at ≤ 32 weeks of
gestation (n = 23) was higher in chronic chorioamnionitis cases (median sample
haptoglobin/pooled sample haptoglobin ratio: 2.9, range: 0.4 – 4.1) compared to both acute
chorioamnionitis cases (median sample haptoglobin/pooled sample haptoglobin ratio: 0.6,
range: 0.4 – 2.3, p<0.05) and control cases (median sample haptoglobin/pooled sample
haptoglobin ratio: 0.7, range: 0.3–2.3, p<0.05) (Figure 5B, 5C), while the difference was not
observed in cases > 32 weeks of gestation (n = 20), as was the case with glycodelin-A.
Glycodelin-A and Haptoglobin Immunoreactivity in the Chorioamniotic Membranes
For the localization of glycodelin-A and haptoglobin expression, sections of the
chorioamniotic membranes were immunostained for glycodelin-A and haptoglobin. Intense
cytoplasmic glycodelin-A immunoreactivity was found in the endometrial epithelial cells.
On the other hand, decidual stromal cells showed a predominantly membranous staining
pattern (Figure 6A and 6B). Haptoglobin immunoreactivity was localized in the cytoplasm
of decidual leukocytes, and also in the cytoplasm of myofibroblasts and macrophages in the
chorioamniotic connective tissue (Figure 6C and 6D). Neutrophil infiltrates in acute
chorioamnionitis were also weakly immunoreactive.
Oggé et al. Page 6
J Pathol. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Discussion
The primary findings of this study are: 1) There are changes in the amniotic fluid proteome
unique to chronic chorioamnionitis compared to acute chorioamnionitis or no inflammation
cases; and, 2) Acute chorioamnionitis and chronic chorioamnionitis are different in terms of
the changes in amniotic fluid IL-6, CXCL8, CXCL10, and PGF2α concentrations. The
changes in amniotic fluid chemokine concentrations (CXCL8, CXCL10) were consistent
with amniotropic infiltration patterns of maternal/fetal neutrophils and maternal T cells in
acute chorioamnionitis and chronic chorioamnionitis, respectively. These observations
further support the fact that acute chorioamnionitis and chronic chorioamnionitis are
manifestations of different pathological processes, particularly in the mechanisms leading to
preterm labor.
Among the changes in amniotic fluid proteome associated with chronic chorioamnionitis,
decreased glycodelin-A concentration is particularly intriguing. Glycodelin, also known as
progesterone-associated endometrial protein, placental protein 14, and progestagen-
dependent endometrial protein, is a dimeric glycoprotein belonging to the lipocalin family
[23,24]. At least four isoforms of identical amino acid sequence but with different
oligosaccharide structures and biological functions are present: glycodelin-A was isolated
from the amniotic fluid [25], glycodelin-F from the follicular fluid [26], glycodelin-C from
the extracellular matrix of the cumulus oophorus [27], and glycodelin-S from epithelial cells
of the seminal glands [28]. The most abundant isoform in the female reproductive tract is
glycodelin-A, which is produced by endometrial and decidual epithelial cells and secreted in
the endometrial fluid and amniotic fluid and into the circulation [24,29]. Glycodelin-A has
two main functions: contraceptive activity due to the inhibition of the binding of
spermatozoa to the zona pellucida [30], and immunosuppression. The immunosuppressive
activity is mediated by several different mechanisms and is effective on all predominant
immune cell lineages at the maternal-fetal interface: lymphocytes, monocytes, and natural
killer cells.
T cells are the most well-defined target of the immunosuppressive action of glycodelin-A.
The proliferative response of T lymphocytes to allogeneic stimulation [31] and to
phytohemagglutinin [32] is inhibited by glycodelin-A in a dose-dependent manner. This
property is dependent on interaction with CD45, a tyrosine phosphatase with regulatory
activity on the T cell receptor signaling pathway, which results in an elevation of the T cell
receptor activation threshold [33]. While both Th1 and Th2 responses are inhibited by
glycodelin-A, the Th1 differentiation pathway is more sensitive to the inhibition of T cell
receptor signaling, thus leading an overall shift toward Th2 differentiation [34]. Moreover,
glycodelin-A induces apoptosis of activated T cells [35] by an intrinsic pathway [36]. The
cell receptor (or one of the receptors) responsible for its apoptotic activity on T cells was
shown to be CD7, a galactose-containing surface glycoprotein expressed in activated T cells.
CD7 is also recognized by galectin-1 and galectin-3 [37]. Glycodelin-A also inhibits
monocyte chemotaxis [38] and induces monocyte apoptosis via the intrinsic mitochondrial
stress-induced pathway [39]. Furthermore, glycodelin-A can inhibit the cytotoxic activity of
circulating natural killer cells [40], possibly through induction of an apoptotic cascade
which, unlike for T cells and monocytes, does not involve the mitochondrial pathway [39].
Because of its abundance at the maternal-fetal interface, it was suggested that glycodelin-A
maintains maternal immune tolerance against fetal allo-antigens [39]. Indeed, a large body
of evidence supports an important role for glycodelin-A in the maintenance of physiologic
pregnancy: 1) women with unexplained infertility have a lower glycodelin-A concentration
in uterine flushing [41]; 2) uterine fluid and serum glycodelin-A concentrations are reduced
in women with a history of recurrent miscarriage [42,43]; 3) glycodelin-A expression is
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reduced in decidual tissues from first-trimester spontaneous abortions compared to normal
pregnancies [44]; and 4) reduced decidual expression of glycodelin-A has been reported in
pregnancies complicated with preeclampsia, HELLP syndrome, and fetal growth restriction,
compared to normal pregnancies [45]. Our observation that amniotic fluid glycodelin-A
concentration is decreased in chronic chorioamnionitis is novel. This strongly suggests that
the impairment of a physiologic constraint of the maternal immune system against fetal
antigens is associated with and precedes the development of chronic chorioamnionitis.
Glycodelin-A production and release are under hormonal control, as it is up-regulated by
progesterone [46], with estrogen exerting a priming effect [47]; human chorionic
gonadotrophin (hCG) also stimulates glycodelin-A expression in endometrial cells [48],
while glycodelin-A induces hCG expression by the cytotrophoblasts [49]. The concentration
of glycodelin-A in the amniotic fluid, as well as in the maternal serum, is known to vary
with gestational age. Amniotic fluid concentration of glycodelin-A increases during early
pregnancy to peak at 15–16 weeks of gestation, and then it rapidly drops until 19 weeks, has
a temporary elevation around 23 weeks, and finally decreases until term [23,50]. A
significant correlation between glycodelin-A concentration and gestational age was also
confirmed in this study. Taken together, the elevation in T cell chemokine CXCL10
concentration and the decreased concentration of the T cell suppressor glycodelin-A in the
amniotic fluid are consistent with the notion that a derangement of the mechanisms
governing maternal immune tolerance toward the semi-allogeneic fetus is involved in the
pathogenesis of chronic chorioamnionitis [11].
This study also identified a set of proteins that were differentially expressed in amniotic
fluid associated with chronic chorioamnionitis cases compared to acute chorioamnionitis
cases or control cases, suggesting chronic chorioamnionitis as a distinct pathological
process. Many of these proteins, such as α 1-antitrypsin, α1-antichymotrypsin, haptoglobin,
ceruloplasmin, and orosomucoid 2 are known as acute phase proteins [51]. These are
mainly, but not exclusively, produced by hepatocytes in response to pro-inflammatory
stimuli, such as infections, trauma, tissue infarction, and cancer [51]. The origin and the role
of these proteins in the amniotic fluid are not yet known; however, they are likely to serve
several functions besides the modulation of the acute inflammatory process. Haptoglobin,
for instance, inhibits T cell response to phytohemagglutinin [52,53], B-cell response to
lipopolysaccharide [54,55] and the release of T helper 2 cytokines IL-4, IL-5, IL-13, and
IL-10 [53]. Moreover, haptoglobin acts as an adipokine with chemotactic action toward
monocytes-macrophages in white adipose tissue [56]. It is therefore plausible that
haptoglobin and other acute phase proteins present in the amniotic fluid are involved in the
immunologic regulation of maternal-fetal interactions, although their roles have yet to be
explored.
In summary, we report unique changes in the amniotic fluid proteome associated with
chronic chorioamnionitis for the first time, and propose that acute chorioamnionitis and
chronic chorioamnionitis comprise two major clusters of spontaneous preterm births having
distinct perturbations in the intra-amniotic protein environment. While acute
chorioamnionitis is a result of microbial invasion of the amniotic cavity and intrauterine
infection [57,58], chronic chorioamnionitis could be a consequence of derangement of the
hormone immune system (progesterone, glycodelin-A) affecting CD8+ T cell activity [59].
The findings herein strongly suggest that compromised tolerogenic pressure in the
intrauterine environment leads to maternal anti-fetal rejection in the form of chronic
chorioamnionitis in the chorioamniotic membranes.
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Figure 1.
Pathologic characteristics of acute and chronic chorioamnionitis. (A, B) Histological
findings of a preterm labor case without inflammation, showing no evidence of extrinsic
infiltrates (A). Few CD8+ T cells (arrows) are found in the decidua (B). (C, D) A case of
acute chorioamnionitis showing characteristic amniotropic neutrophil infiltration into the
chorionic connective tissue layer (C). CD8+ T cells (arrows) are restricted to the decidual
layer (D). (E, F) A case of chronic chorioamnionitis with infiltration of lymphohistiocytes
into the chorionic trophoblast layer (E), which are predominantly of CD8+ T cells (arrows)
(F). Original magnification (A–F), X200.
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Figure 2.
Differences in amniotic fluid IL-6, CXCL8, CXCL10, and PGF2α concentrations according
to the type of inflammation in preterm labor cases (n=125). (A, B) Amniotic fluid IL-6 and
CXCL8 concentrations are elevated in cases of acute but not chronic chorioamnionitis. (C)
Amniotic fluid CXCL10 concentration is elevated in cases of chronic but not acute
chorioamnionitis. (D) Amniotic fluid PGF2α concentration in each group, showing an
elevation in acute chorioamnionitis cases compared to other groups. ACA: acute
chorioamnionitis, CCA: chronic chorioamnionitis.
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Figure 3.
Amniotic fluid IL-6 (A), CXCL8 (B), CXCL10 (C), and PGF2α (D) concentrations in
preterm labor cases without inflammation (n=71) and term not in labor cases (n=22).
Amniotic fluid CXCL8 and PGF2α concentrations are significantly higher in term not in
labor cases than in preterm labor cases (p<0.01 and p<0.001, respectively), whereas there is
no difference in IL-6 and CXCL10 concentrations. PTL: preterm labor, TNL: term not in
labor.
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Figure 4.
Identification of differentially abundant proteins in amniotic fluid samples from chronic
chorioamnionitis cases. (A) Two-dimensional difference in gel electrophoresis (2D-DIGE)
images showing differentially expressed proteins between acute chorioamnionitis cases
(Cy3: green) and chronic chorioamnionitis cases (Cy5: red). The spots are labeled by
number. (B) Three-dimensional images from DeCyder software analysis for spot 42 marked
in the 2D-DIGE image (A), which is increased in chronic chorioamnionitis. The spot was
identified as β-haptoglobin by MALDI-TOF-MS/MS. ACA: acute chorioamnionitis, CCA:
chronic chorioamnionitis.
Oggé et al. Page 16
J Pathol. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5.
Differential abundance of glycodelin-A and β-haptoglobin in chronic chorioamnionitis cases
with gestational ages of 32 weeks or less. (A) Amniotic fluid glycodelin-A concentration is
significantly lower in chronic chorioamnionitis cases (n=21) compared to that of control
cases (n=37) and acute chorioamnionitis cases (n=10). (B) Immunoblotting results showing
increased abundance of β-haptoglobin subunit in chronic chorioamnionitis cases. Amniotic
fluid (3.5 μl) was electrophoresed in 12% SDS-PAGE under reducing conditions. P: a
pooled amniotic fluid sample as a normalizer in densitometric analysis. (C) The results of
densitometric analysis of β-haptoglobin immunoblotting. Haptoglobin is significantly
increased in the amniotic fluid of chronic chorioamnionitis cases (n=8) compared to control
cases (n=8) and to acute chorioamnionitis cases (n=7). The graph depicts the relative density
of each sample using the density of a pooled amniotic fluid sample as a normalizer. ACA:
acute chorioamnionitis, CCA: chronic chorioamnionitis.
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Figure 6.
Immunoreactivity of glycodelin-A and haptoglobin in the chorioamniotic membranes. (A)
Distinct glycodelin-A immunoreactivity in the endometrial epithelial cytoplasm (arrows) in
a preterm labor case without inflammation. Membranous immunoreactivity is far more
prominent in the decidual stromal cells. (B) A chronic chorioamnionitis case showing
similar immunoreactive patterns in the endometrial epithelial cytoplasm (arrows). (C–F)
Coarsely granular haptoglobin immunoreactivity is mainly found in decidual leukocytes and
in myofibroblasts (C) and macrophages of the chorionic connective tissue from a preterm
labor case without inflammation (E). Similar immunoreactive patterns also found in a
chronic chorioamnionitis case. Decidual leukocytes (D) and myofibroblasts and
macrophages in the chorionic connective tissue (F). Original magnification (A, B), X200;
(C–F), X400.
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Table 1
Demographic and clinical characteristics of the study population
ACA−/CCA− (n=71) ACA+/CCA− (n=14) ACA−/CCA+ (n=40)
Maternal age (years) 23.5 (±5.7) 24.3 (±8.9) 24.7 (±6.6)
Nulliparous 31 (43.7%) 8 (57.1%) 15 (37.5%)
GA at amniotic fluid sampling (weeks) 31.0 (±3.0) 29.8 (±3.5) 31.4 (±2.8)
GA at delivery (weeks)† 36.5 (±2.9) 32.9 (±5.5)* 35.4 (±3.7)
Interval amniocentesis-delivery (days) † 38.2 (±28.5) 22.0 (±24.9) 28.3 (±23.6)
Birth weight (grams) † 2753.7 (±712.7) 2155.0 (±1125.2)** 2548.3 (±844.1)
Birth weight <10th percentile 11 (15.5%) 1 (7.1%) 7 (17.5%)
Data are presented as mean (±SD) or number (percentage)
†
p <0.05 among three groups
*
p <0.05 compared to ACA−/CCA−
**
p <0.05 compared to both ACA-/CCA− and ACA−/CCA−
ACA: acute chorioamnionitis, CCA: chronic chorioamnionitis, GA: gestational age.
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Table 2
Amniotic fluid peptides showing significant changes with chronic chorioamnionitis cases compared to acute
chorioamnionitis cases or cases without chorioamnionitis
Spot number Protein name Accession number MW (Da) Protein PI
4 Proteoglycan 2 preproprotein gi|46276889 25189.3 6.3
7 Ceruloplasmin gi|1620909 115398.4 5.4
8 Albumin preproprotein gi|4502027 69321.5 5.9
10 Serum albumin precursor gi|6013427 69180.4 5.9
13 Complement component 6 gi|38488662 104739.1 6.4
15 Complement factor B gi|13278732 85508.5 6.6
19 Plasminogen gi|4505881 90510.2 7.0
22 Transferrin gi|115394517 76909.6 7.0
25 Alpha-2-HS-glycoprotein gi|156523970 39315.7 5.4
27 Alpha-1-antichymotrypsin precursor gi|177933 45453.4 5.3
28 Kininogen 1 variant gi|62898910 47822.6 6.3
29 Alpha-1 antitrypsin variant gi|110350939 46577.0 5.4
30 Chain A, the intact and cleaved human antithrombin III complex gi|999513 49008.0 6.0
32 Chain A, structure of human serum albumin with S-Naproxen and the Ga
module
gi|168988718 65777.6 5.6
36 Vitamin D-binding protein/group specific component gi|455970 52916.0 5.3
40 Chain A, crystal structure of a Serpin:protease complex gi|11514321 37624.4 5.3
42 Haptoglobin gi|3337390 38209.2 6.1
45 PRO2619 gi|11493459 56745.2 6.0
47 Hemopexin, isoform CRA_d gi|119589127 43201.2 6.2
48 Phosphogluconate dehydrogenase gi|40068518 53105.9 6.8
49 Enolase 1 variant gi|62897945 47167.3 7.0
52 Albumin-like gi|763431 52047.8 5.7
55 Leucine-rich alpha-2-glycoprotein 1 gi|16418467 38154.1 6.5
61 Progestagen-associated endometrial protein gi|55958594 14792.5 5.2
62 Chain A, crystal structure of lipid-free human apolipoprotein A-I gi|90108664 28061.5 5.3
63 Orosomucoid 2 gi|48145977 23599.7 5.0
64 Chain A, crystal structure of the trigonal form of human plasma retinol-
binding protein
gi|157830446 20945.1 5.3
65 Chain E, crystal structure of the transthyretin-retinol binding protein-Fab
complex
gi|212374946 20189.7 5.1
67 Insulin-like growth factor binding protein 1 precursor gi|4504615 27885.3 5.1
68 Chain B, structural basis for the inhibition of insulin-like growth factors by
Igf binding proteins
gi|114793741 9808.5 5.3
71 Albumin, isoform CRA_p gi|119626079 22498.5 8.2
Spot numbers shown in 2D-DIGE image (Figure 2A).
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